ADAR1 Capital Management »

Polypid shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Polypid (PYPD) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Polypid

Jun 302024Jul 14Jul 28Aug 11Aug 25Sep 8Sep 22350k400k450k95k100k
Value ($)Share countHistorical PYPD position of ADAR1 Capital Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Polypid held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Polypid by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $323k 94k 3.44
2024-06-30 $447k 104k 4.30

More positions owned by ADAR1 Capital Management

Cytokinetics Com New (CYTK)
Protagonist Therapeutics (PTGX)
Bridgebio Pharma (BBIO)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Zura Bio Class A Ord Shs (ZURA)
Zai Lab Adr (ZLAB)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Aa Mission Acquisition Corp Ord Shs Cl A (AAM)
Mineralys Therapeutics (MLYS)
Syndax Pharmaceuticals (SNDX)

View all positions for ADAR1 Capital Management

Top funds holding Polypid

Rosalind Advisors
AIGH Capital Management
DAFNA Capital Management
J. Goldman & Co
Stonepine Capital Management
ADAR1 Capital Management
Yelin Lapidot Holdings Management
Steward Partners Investment Advisory
Morgan Stanley
Bnp Paribas Arbitrage, Snc
TD Waterhouse Canada
Advisor Group Holdings
UBS Group
SBI Securities

View all funds holding Polypid